Express

Leading Pharmaceutical Biotechnology Soars Nearly 240% Intraday, Announces Plan to Acquire Conflux

Summary: Leading Pharmaceutical Biotechnology, a Hong Kong-listed company, surged significantly in early trading today, rising nearly 240% at one point before narrowing gains. The stock price reached 0.7 Hong Kong dollars before retreating to around 0.34 Hong Kong dollars. The company had previously announced plans to acquire all shares of Conflux to expand into the blockchain ...

Leading Pharmaceutical Biotechnology, a Hong Kong-listed company, surged significantly in early trading today, rising nearly 240% at one point before narrowing gains. The stock price reached 0.7 Hong Kong dollars before retreating to around 0.34 Hong Kong dollars. The company had previously announced plans to acquire all shares of Conflux to expand into the blockchain sector, with two founding members of Conflux serving as its executive directors.

Last Update:

Tags:
Link: Leading Pharmaceutical Biotechnology Soars Nearly 240% Intraday, Announces Plan to Acquire Conflux [Copy]

Last: 1RT Acquisition Corp. Plans to Raise $150 Million Through IPO to Expand Digital Assets, Fintech Business

Next: Analysis: Strengthening Cooperation between Hong Kong and Shanghai to Form a Positive Development Pattern for Onshore Digital RMB and Offshore RMB Stablecoins

The Crypto Treasury Boom Meets Regulatory Chill: Is the DAT Frenzy Fading? 21 hours ago

Nasdaq Takes Aim at 'Crypto-Flipping' Companies with Stricter Rules 5 days ago

BTC Weekly Outlook: The Oversold Bounce—A Bottom or a Shorting Opportunity? 8 days ago

The Making of a Political Darling: Is Chainlink’s Government Deal a Victory for Tech or... 12 days ago

Google Steps Into Blockchain: A New Front in the “Ledger Wars” 14 days ago